Published by ChinaMNC · Xiahe

US Adds Chinese Firms to Xinjiang-Linked Entity List: What Foreign Founders Should Know

China's Ministry of Commerce condemned a US decision to add three more Chinese entities to the so-called Uyghur Forced Labor Prevention Act entity list, warning of countermeasures. Here is what the development means for foreign founders operating or registering companies in China.

US Expands Xinjiang-Linked Entity List, China Vows Countermeasures

On October 28, the US Department of Homeland Security announced that three additional Chinese entities would be added to the entity list under the so-called Uyghur Forced Labor Prevention Act. China's Ministry of Commerce responded the following day through a spokesperson's remarks published on its official website, rejecting the move and outlining Beijing's position.

For foreign founders building or running businesses in China, the exchange is a reminder that US-China trade tensions can spill into compliance and supply-chain decisions. The following summarizes what the Ministry of Commerce said, without adding facts beyond the official statement.

What the Ministry of Commerce Said

Asked for comment on the US announcement, the ministry spokesperson said China had noted the development. The spokesperson stated that forced labor does not exist in China, that people of all ethnic groups in Xinjiang enjoy free and equal access to employment, and that their labor rights are effectively protected in accordance with the law.

The spokesperson described the US measures as lacking any factual basis and characterized them as part of an ongoing effort by Washington to use human rights issues as a cover for unilateral protectionism and bullying. China, the spokesperson said, strongly condemns and firmly opposes the measures.

Prior Listings and Chinese Countermeasures

According to the spokesperson, the US had already added a large number of Chinese entities to the so-called Xinjiang-related entity list not long before this latest action. China said it lodged solemn representations with the US and took firm countermeasures in response.

The spokesperson said the US did not change course and, despite China's firm opposition, proceeded with new sanctions, including placing Chinese biopharmaceutical technology companies on a sanctions list.

Why the Ministry Says the Listings Matter

The spokesperson argued that the US listing practice departs from the consensus reached by the heads of state of the two countries, seriously undermines the stability of China-US economic and trade relations, and runs counter to humanitarian principles.

The ministry called on the US to immediately stop what it described as political manipulation and smear campaigns and to stop unjustified suppression of Chinese companies. It added that China will take necessary measures to firmly safeguard its own interests.

What This Means for Foreign Founders in China

The statement does not introduce new rules for foreign-invested companies, nor does it change the registration process for setting up a business in China. It is a political and diplomatic response to a US action. Still, founders should keep several practical points in mind.

• Supply-chain screening matters. If your China-based operations export to the US or sit inside a supply chain that touches US customers, US entity-list designations can affect counterparties' willingness to trade. Review your suppliers and customers against relevant US lists as part of routine due diligence.
• Watch for countermeasures. China said it has already taken countermeasures and will take necessary measures to protect its interests. The exact scope of those measures is not detailed in the statement, so monitor official announcements if your business depends on cross-border trade.
• Keep documentation. The dispute centers on allegations about labor practices. Companies with China-based manufacturing or sourcing should maintain clear records of their own labor and sourcing arrangements.
• Separate registration from geopolitics. Forming a wholly foreign-owned enterprise, a joint venture, or a representative office in China remains a domestic registration process governed by Chinese company law and local authorities. The ministry's statement does not alter those procedures.
• Track bilateral signals. The spokesperson referenced the consensus between the two countries' heads of state. Shifts in that relationship can affect the tone of enforcement and the speed of approvals in affected sectors.

Sectors to Watch

The statement specifically mentions Chinese biopharmaceutical technology companies as targets of the latest US sanctions. Founders in life sciences, medical technology, and related supply chains should pay particular attention to how listing decisions evolve. The statement does not identify the companies involved or describe the sanctions in detail.

What the Statement Does Not Say

The Ministry of Commerce remarks do not announce new Chinese regulations, tax changes, or registration requirements. They do not set out a timeline for countermeasures, and they do not name the three entities added by the US. Founders should treat the statement as an official expression of the Chinese government's position rather than as a compliance guide.

For companies weighing whether to establish or expand a China presence, the practical takeaway is to build geopolitical risk into planning. That means knowing which US and Chinese lists may apply to your partners, keeping clean records, and getting local advice on entity structure and ongoing compliance.

Next Steps for Founders

If you are registering a company in China or already operating one, review your exposure to cross-border restrictions and confirm that your local filing and reporting obligations are up to date. Official ministry statements like this one are worth monitoring because they can signal shifts in the business environment before formal rules change.

Foreign founders who need help registering and operating a company in China can contact ChinaMNC on WhatsApp or WeChat at +86 153 1898 8535.

This summary is based on information published by the relevant Chinese government website and is general information, not legal or tax advice.